lung – media

Lung Macrophages Affected by E-Cigarette Vapour

Findings from a new study revealed that e-cigarette vapor is responsible for the development of inflammatory mediators in the lungs and also for the hampering of chief disease-fighting cells.
- Source: Reuter
- 576
- August 24, 2018
lung Researches vaping
A Chicken Bone in your Lungs?

However, after five days, he was again sent to the emergency room due to fever, breathing difficulty and high-pitched wheezing sound while inhaling. The doctors immediately performed a CT scan, which revealed a chicken bone in the right bronchus (the branching part from the trachea into the lung).
- Source: Ddu
- 515
- June 1, 2018
lung Researches
North Colorado Medical Center invests nearly $2 million in new robotic surgery technology

Maurice Lyons remembers when lung surgery used to require him to make a 6-10 inch incision in a patients' skin and fracture a rib. He'd take the lung out, do what needed to be done and put it back. It would take patients about a week to recover enough just to leave the hospital, Lyons said.
- Source: The Tribune
- 561
- January 30, 2018
Company Insight lung medical device medtech surgery
Researchers show aspirin added to cancer drug improves effectiveness

Adding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment, new research has shown.
- Source: medicalxpress
- 593
- December 5, 2017
aspirin cancer colorectal lung pancreatic Researches
Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo

Merck took a dominant position in frontline lung cancer with the approval of a combination of Keytruda and chemo. And it isn’t just waiting around to see if any combination of a PD-(L)1 with a CTLA4 can come along and knock it off its market-leading perch.
- Source: Endpts
- 615
- October 9, 2017
cancer Clinical Trials lung Phase
EU green light for Roche’s Tecentriq

Roche has received European Commission(EC) approval for its anti-PD-L1 cancer immunotherapy Tecentriq (atezolizumab) to treat specific lung and bladder cancers. The green light means that it can be used as monotherapy for people in the EU with previously-treated locally advanced or metastatic non-small cell cancer (NSCLC), or those with metastatic urothelial carcinoma (mUC) who have received a platinum-based chemotherapy or who are ineligible to receive cisplatin chemotherapy.
- Source: Pharmatimes
- 562
- September 26, 2017
bladder cancer Company Insight immunotherapy lung
FDA grants fast-track designation for Shire’s lung drug

The FDA has granted Fast Track designation to Shire's SHP607 for the prevention of chronic lung disease in extremely premature infants.
- Source: Pharmatimes
- 581
- September 14, 2017
chronic Clinical lung New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.